Onconova Therapeutics Inc
Biotechnology
Healthcare
ONTX
20.91 M shares
NASDAQ US
traded
08 May 2023
listed
yes
open
1.38
52 week high
7.56
high
1.45
52 week low
1.32
low
1.35
growth
-1.39 %
previous Close
1.40
P/E ratio
market cap
27.26 M
div yield
0
usd
Dec 2022
qoq
revenue
56.00 K
-1.75 %
net incoming
-5.00 M
7.37 %
eps
0.00 %
0.00 %
eps surprise
7.14 %
net profit margin
-8928.57 %
541.00 %
operating incoming
-5.73 M
-1.65 %
net change in cash
-3.86 M
1.63 %
cash on hand
38.76 M
-9.05 %
cost of revenue
0.00 %
top top